Department of Health and Human Services$1.1M obligationsEnds Dec 18, 2021
Federal contract award
HHSN27200009
IGF::OT::IGF SUPPORT FOR ENHANCING STUDY DRUG ADHERENCE IN HIV PREVENTION TRIALS
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541712 |
| PSC | AN81 — AIDS RESEARCH - BASIC RESEARCH |
| Parent award / vehicle | HHSN272201600008I |
| Set-aside | Not reported |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $844.7K |
| Current contract value | $844.7K |
| Potential contract value / ceiling | $844.7K |
| Start date | Jul 27, 2017 |
| Current end date | Jul 31, 2020 |
| Potential end date | Jul 31, 2023 |
| Latest award activity | Jun 7, 2024 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 9 of 9 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jun 7, 2024 | P00008 | $-877 | SUPPORT FOR ENHANCING STUDY DRUG ADHERENCE IN HIV PREVENTION TRIALS |
| Aug 7, 2023 | P00007 | $940 | SUPPORT FOR ENHANCING STUDY DRUG ADHERENCE IN HIV PREVENTION TRIALS |
| Sep 14, 2022 | P00006 | $10.6K | TO PROVIDE EXPERTISE RELATED TO THE ENHANCEMENT OF STUDY DRUG ADHERENCE AND UPTAKE IN HIV PREVENTION TRIALS BY COLLABORATING WITH NIAID STAFF IN: 1) THE PLANNING OF RESEARCH ACTIVITIES IN TARGET POPULATIONS AT HIGH RISK OF HIV INFECTION, AND 2) THE |
| May 26, 2022 | P00005 | $147.1K | TO PROVIDE EXPERTISE RELATED TO THE ENHANCEMENT OF STUDY DRUG ADHERENCE AND UPTAKE IN HIV PREVENTION TRIALS BY COLLABORATING WITH NIAID STAFF IN: 1) THE PLANNING OF RESEARCH ACTIVITIES IN TARGET POPULATIONS AT HIGH RISK OF HIV INFECTION, AND 2) THE |
| Jun 22, 2021 | P00004 | $143.8K | TO PROVIDE EXPERTISE RELATED TO THE ENHANCEMENT OF STUDY DRUG ADHERENCE AND UPTAKE IN HIV PREVENTION TRIALS BY COLLABORATING WITH NIAID STAFF IN: 1) THE PLANNING OF RESEARCH ACTIVITIES IN TARGET POPULATIONS AT HIGH RISK OF HIV INFECTION, AND 2) THE |
| Jun 8, 2020 | P00003 | $140.5K | TO PROVIDE EXPERTISE RELATED TO THE ENHANCEMENT OF STUDY DRUG ADHERENCE AND UPTAKE IN HIV PREVENTION TRIALS BY COLLABORATING WITH NIAID STAFF IN: 1) THE PLANNING OF RESEARCH ACTIVITIES IN TARGET POPULATIONS AT HIGH RISK OF HIV INFECTION, AND 2) THE |
| Jun 12, 2019 | P00002 | $137.3K | TO PROVIDE EXPERTISE RELATED TO THE ENHANCEMENT OF STUDY DRUG ADHERENCE AND UPTAKE IN HIV PREVENTION TRIALS BY COLLABORATING WITH NIAID STAFF IN: 1) THE PLANNING OF RESEARCH ACTIVITIES IN TARGET POPULATIONS AT HIGH RISK OF HIV INFECTION, AND 2) THE INTERPRETATION OF DATA AND RESULTS FROM ONGOING OR FUTURE NIAID-SUPPORTED RESEARCH STUDIES. |
| Jun 26, 2018 | 1 | $134.2K | TO PROVIDE EXPERTISE RELATED TO THE ENHANCEMENT OF STUDY DRUG ADHERENCE AND UPTAKE IN HIV PREVENTION TRIALS BY COLLABORATING WITH NIAID STAFF IN: 1) THE PLANNING OF RESEARCH ACTIVITIES IN TARGET POPULATIONS AT HIGH RISK OF HIV INFECTION, AND 2) THE INTERPRETATION OF DATA AND RESULTS FROM ONGOING OR FUTURE NIAID-SUPPORTED RESEARCH STUDIES. |
| Jul 27, 2017 | 0 | $131.1K | IGF::OT::IGF SUPPORT FOR ENHANCING STUDY DRUG ADHERENCE IN HIV PREVENTION TRIALS |
Research next steps
- Verify whether remaining options may extend performance beyond the current end date.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.